Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-16-080945
Filing Date
2016-09-29
Accepted
2016-09-28 18:50:54
Documents
1
Effectiveness Date
2016-09-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8331
  Complete submission text file 0001140361-16-080945.txt   9375
Mailing Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139
Business Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139 650-463-4052
Cure Forward Corp. (Filer) CIK: 0001624526 (see all company filings)

EIN.: 461272619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-271499 | Film No.: 161908031